Drug Trial Radar · NCT05397639
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
375
Planned (sponsor's estimate)
Start
Nov 1, 2022
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Suven Life Sciences LimitedIndustry
- Sponsor type
- Industry
- First posted
- May 31, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.
Conditions
- Agitation
- Alzheimer's Type Dementia
Interventions
Masupirdine 50 mgDrug
Tablet, Once Daily
Masupirdine 100 mgDrug
Tablet, Once Daily
PlaceboDrug
Matching Placebo Tablet, Once Daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohen-Mansfield Agitation Inventory (CMAI)Time frame: From Baseline to Week 12 visit
Locations
44 sites in 4 countries. Site status is shown where the registry gives one.
Advanced Research Center, Inc.
Anaheim, California
ATP Clinical Research, Inc.
Costa Mesa, California
Leading Edge Research LA, LLC
Encino, California
Neuro Pain Medical Center
Fresno, California
Neurology Center of North Orange County
Fullerton, California
Mary S Easton Center for Alzheimer's Research and Care UCLA
Los Angeles, California
Ki Health Partners, LLC
Stamford, Connecticut
Allied Biomedical Research Institute
Miami, Florida
Central Miami Medical Institute
Miami, Florida
CCM Clinical Research Group
Miami, Florida
Miami Jewish Health
Miami, Florida
Novel Clinical Research Center, LLC.
Miami, Florida
Brainstorm Research
Miami, Florida
Combined Research Orlando Phase I-IV
Orlando, Florida
Quantum Laboratories Inc
Pompano Beach, Florida
Re:Cognition Health
Chicago, Illinois
Insight Hospital and Medical Center Chicago
Chicago, Illinois
Ocean Medical Research
Toms River, New Jersey
Dent Neurologic Institute
Amherst, New York
Velocity Clinical Research, Syracuse
East Syracuse, New York
Velocity Clinical Research, Cleveland
Beachwood, Ohio
Ralph H. Johnson VA Health Care System
Charleston, South Carolina
Midlands Neurology and Pain Associates
Columbia, South Carolina
Gadolin Research
Beaumont, Texas
Re:Cognition Health
Fort Worth, Texas
Baylor College of Medicine
Houston, Texas
Clinical Trial Network
Houston, Texas
Clinical Hospital Center Rijeka
Rijeka, Croatia
Polyclinic Neuron
Zagreb, Croatia
University Hospital Center Zagreb
Zagreb, Croatia
Klinika za psihijatriju Vrapce
Zagreb, Croatia
ClinHouse Centrum Medyczne
Zabrze, Poland
Medycyna Milorzab sp. z o.o.
Lodz, Lódzkie, Poland
FutureMeds Warszawa Centrum
Warsaw, Masovian Voivodeship, Poland
MTZ Clinical Research powered by Pratia
Warsaw, Masovian Voivodeship, Poland
Centrum Leczenia Zaburzen Pamieci Affidea
Warsaw, Masovian Voivodeship, Poland
Centrum Medyczne Silmedic Sp z o o
Katowice, Silesian Voivodeship, Poland
EMC Silesia Sp. z o.o.
Katowice, Silesian Voivodeship, Poland
Neuro-Medic Janusz Zbrojkiewicz
Katowice, Silesian Voivodeship, Poland
Clinical Hospital Center Dragisa Misovic Dedinje
Belgrade, Serbia
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.